We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 129

New infringement lawsuit filed to protect BRCA1 and BRCA2 patents
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

Myriad Genetics has brought a new infringement lawsuit against a company offering a next-generation sequencing test that analyzes the BRCA1 and BRCA2


USPTO proposes changes to patent term adjustment
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

In response to the Federal Circuit Court of Appeals ruling in Novartis AG v. Lee, summarized in Issue 71 of this Bulletin, the U.S. Patent and


Federal court upholds FTC rules on reporting certain pharma patent transfers
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2014

Granting the agency's motion for summary judgment, a federal court in the District of Columbia has upheld the U.S. Federal Trade Commission's (FTC's


SCOTUS reverses Federal Circuit patent ruling
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2014

The U.S. Supreme Court has reversed a Federal Circuit Court of Appeals decision on induced infringement, ruling that a defendant cannot be


Court finds no standing for Consumer Watchdog in stem cell patent appeal
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2014

The Federal Circuit Court of Appeals has rejected not-for-profit Consumer Watchdog's appeal of the U.S. Patent and Trademark Office's (USPTO's


New Patent Trial and Appeal Board becomes strategic venue of choice
  • Shook Hardy & Bacon LLP
  • USA
  • October 31 2013

According to a news source, companies hoping to prevail in patentinfringement lawsuits have turned with increasing frequency to the Patent Trial and


Ambry Genetics countersues Myriad Genetics in genetic patent infringement suit
  • Shook Hardy & Bacon LLP
  • USA
  • August 15 2013

Responding to the patent infringement claims asserted against it by Myriad Genetics, Ambry Genetics Corp. denies that the 15 patents at issue were


Federal Circuit reminds litigants to cross-appeal patent invalidity claim
  • Shook Hardy & Bacon LLP
  • USA
  • March 21 2013

The Federal Circuit Court of Appeals, in the context of patents on improvements to electronic animal collars, has in large part affirmed a lower


Federal Circuit upholds inequitable conduct ruling; patent unenforceable
  • Shook Hardy & Bacon LLP
  • USA
  • October 17 2013

The Federal Circuit Court of Appeals has determined that a district court did not err in finding that the inequitable conduct of the inventor of


Challenge to AIA first-to-file rule fails for lack of standing
  • Shook Hardy & Bacon LLP
  • USA
  • July 17 2014

Ruling that it had jurisdiction to consider a constitutional challenge to the America Invents Act (AIA), the Federal Circuit Court of Appeals has